Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment

Thorax

Volumn 57, Issue 12, 2002, Pages 1085-1086

  Yano, S ^a  

^a National Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ESTROGEN RECEPTOR; ETHINYLESTRADIOL PLUS NORGESTREL; HEMOSIDERIN; PARAFFIN; PROGESTERONE RECEPTOR;

ADULT; ARTERIAL GAS; ARTERIAL PH; ARTICLE; BRONCHIOLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE EXACERBATION; DYSPNEA; ENZYME BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FEMALE INFERTILITY; FORCED EXPIRATORY VOLUME; HEMOPTYSIS; HUMAN; HYPERPLASIA; IMMUNOREACTIVITY; INFERTILITY THERAPY; KIDNEY POLYCYSTIC DISEASE; LEUKOCYTE COUNT; LUNG; LUNG ALVEOLUS OXYGEN TENSION; LUNG ALVEOLUS WALL; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LYMPHANGIOLEIOMYOMATOSIS; PRIORITY JOURNAL; SCLEROSIS; SMOOTH MUSCLE; SPIROMETRY; SYMPTOM; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

ADULT; DYSPNEA; ESTROGENS; FEMALE; HUMANS; INFERTILITY, FEMALE; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS;

EID: 0036898864     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.12.1085     Document Type: Article

References (13)

1. Logginidou H, Xiang A, Russo I, et al. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest 2000;117:25-30.
2. Sieker OH, McCarty KS. Lymphangioleiomyomatosis: A respiratory illness with an endocrinologic therapy. Trans Am Clin Climatol Assoc 1987;99:55-67.
3. Taylor JR, Ryu J, Colby TV, et al. Lymphangioleiomyomatosis: Clinical course in 32 patients. N Engl J Med 1990;323:1254-60.
4. Baldi S, Papotti M, Valente ML, et al. Pulmonary lymphangioleiomyomatosis in postmenopausal women: Report of two cases and review of the literature. Eur Respir J 1994;7:1013-6.
5. Zanella A, Toppan P, Nitti D, et al. Pulmonary lymphangioleiomyomatosis: A case report in postmenopausal women treated with pleurodesis and progesterone (medoxyprogesterone acetate). Tumori 1996;82:96-8.
6. Eugene JS. Lymphangioleiomyomatosis. A review. Chest 1998;114:1689-703.
7. Talmadge EK, Robert SC. Pulmonary lymphangioleiomyomatosis. In: Fishman AP, ed. Fishman's Pulmonary Diseases and Disorders. New York: McGraw-Hill, 1998: 1171-8.
8. Jozwiak S. Pulmonary lymphangioleiomyomatosis: A "forme fruste" of tuberous sclerosis? AJR 1990;155:419.
9. Valensi QJ. Pulmonary lymphangioleiomyomatosis, a probable forme fruste of tuberous sclerosis. Am Rev Respir Dis 1973;108:1411-5.
10. Gomez MR. Exacerbation of LAM. In: Bradley WG, Daroff RB, Fenichel GM, et al, eds. Neurology in Clinical Practice. Boston: Butterworth-Heinemann, 1996: 1566-72.
11. van Slegtenhorst, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805-8.
12. European Chromosome Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-15.
13. Franz DN, Brody A, Meyer C, et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 2001;164:661-8.